MAOA, monoamine oxidase A, 4128

N. diseases: 300; N. variants: 15
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 Biomarker phenotype BEFREE Monoamine oxidase-A (MAOA) metabolises monoamines and is implicated in the pathophysiology of psychiatric disorders. 29667298 2019
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 Biomarker phenotype BEFREE Monoamine oxidase A (MAO-A) plays an important role in various functions of the brain, such as regulation of mood, anxiety and aggression, and dysregulation of MAO-A is observed in stress-related psychiatric disorders. 30687104 2018
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 AlteredExpression phenotype BEFREE MAO A knockout mice were found to display high levels of intermale aggression; however, further analyses of these mutants unveiled additional behavioral abnormalities mimicking the core symptoms of autism-spectrum disorder. 29748850 2018
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 Biomarker phenotype BEFREE However, MAO-A inhibitors, which directly acts on MAO-A protein, have limited use due to their adverse effects. microRNAs (miRNAs) are 18-22 nucleotide long, small non-coding RNAs, which have recently emerged as regulators of protein levels that could potentially be new therapeutic targets for psychiatric disorders. 30271325 2018
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 Biomarker phenotype BEFREE Previous studies have showed associations of serotonin transporter (5-HTT) and monoamine oxidase A (MAOA) with behavioral and psychiatric disorders. 30126429 2018
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 Biomarker phenotype BEFREE Collectively, we confirmed that MAOA is a risk gene for psychiatric disorders, and our results provide useful information toward a better understanding of genetic mechanism involving MAOA underlying risk of complex psychiatric disorders. 26227907 2016
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 Biomarker phenotype BEFREE Monoamine oxidase A (MAOA), a catecholamine neurotransmitter degrading enzyme, is closely associated with neurological and psychiatric disorders. 24607627 2014
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 GeneticVariation phenotype BEFREE We studied postinstitutionalized adopted Chinese girls to determine whether those with different variants of the MAOA gene promoter region (MAOA-VNTR) differed in their internalizing and externalizing behavior problems and whether the MAOA genotype moderated the relation between preadoption adversity and current behavior problems. 25028974 2014
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 Biomarker phenotype BEFREE Patients who lack both MAOA and MAOB have the most extreme laboratory values (urine, blood, and CSF serotonin 4-6 times normal, with elevated O-methylated amine metabolites and reduced deaminated metabolites) in addition to severe intellectual deficiency and behavioral problems. 22365943 2012
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 GeneticVariation phenotype BEFREE This review tries to cover the literature on the impact of gene variants implicated in psychiatric disorders on serotonin, dopamine, and MAO-A radioligand binding in living humans. 20399868 2010
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 GeneticVariation phenotype BEFREE The MAO-A gene, platelet MAO-B activity and psychosocial environment in adolescent female alcohol-related problem behaviour. 18029114 2008
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 GeneticVariation phenotype BEFREE The results suggest that both maltreatment and MAO-A genotype may be useful for the understanding of male adolescent alcohol-related problem behaviour. 17298646 2007
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 GeneticVariation phenotype BEFREE In the present study, the association between the monoamine oxidase A variable number tandem repeat polymorphism and personality traits assessed by the Temperament and Character Inventory was examined in 324 Japanese volunteers without psychiatric disorders. 16538181 2006
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 Biomarker phenotype BEFREE These findings in a different culture further support the influence of the MAOA-uVNTR in psychiatric disorders. 16526025 2006
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 GeneticVariation phenotype BEFREE By conferring allele-specific transcriptional activity on the monoamine oxidase A (MAOA) gene in humans, length variation of a repetitive sequence [(variable number of tandem repeat (VNTR)] in the MAOA promoter influences a constellation of personality traits related to aggressive and antisocial behavior and increases the risk of neurodevelopmental and psychiatric disorders. 16436187 2006
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 GeneticVariation phenotype BEFREE Overall, our results, albeit not definitive, are consistent with the hypothesis that variants in MAOA account for a small portion of the variance of SUD risk, possibly mediated by liability to early onset behavioral problems. 14755456 2004
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 GeneticVariation phenotype BEFREE A functional polymorphism (the upstream variable-number tandem repeat region, or uVNTR) in the monoamine oxidase A (MAOA) promoter region has been reported to be associated with behavioral abnormalities as well as increased serotonergic responsivity. 12919132 2003
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 Biomarker phenotype BEFREE Monoamine oxidase type A (MAOA) has been implicated to be part of mechanisms underlying human temperament and psychiatric disorders. 12566936 2002
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 Biomarker phenotype BEFREE We then examined genetic polymorphisms in four candidate genes (DRD4, DAT, COMT and MAOA) that have been shown to contribute to the risk of developing various psychiatric disorders where attention is disrupted. 12366871 2002
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 GeneticVariation phenotype BEFREE To investigate the possible influence of the allelic variants of the MAOA gene-linked polymorphic region (MAOA-LPR) on the genetic predisposition to psychiatric disorders, we have performed a case-control association study. 11304831 2001
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 GeneticVariation phenotype BEFREE We have examined a VNTR polymorphism at the X-linked MAOA gene to test two hypotheses: (1) Do variants of the MAOA gene play a role in any of the behavioral disorders associated with Tourette syndrome or drug abuse? 9491813 1998
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 GeneticVariation phenotype BEFREE Lack of monoamine oxidase A (MAO-A) due to either Xp chromosomal deletions or alterations in the coding sequence of the gene for this enzyme are associated with marked changes in monoamine metabolism and appear to be associated with variable cognitive deficits and behavioral changes in humans and in transgenic mice. 9564605 1998
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 GeneticVariation phenotype BEFREE The recent finding that a mutation in the structural gene for the enzyme monoamine oxidase A is associated, in several males of a large kindred, with borderline mental retardation and abnormal behavior is an important breakthrough in the field. 7919920 1994
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 GeneticVariation phenotype BEFREE Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. 8211186 1993
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.200 Biomarker phenotype HPO